Drug Topics October 25, 2024
Brian Nowosielski

As the H5 bird flu outbreak gradually impacts human health in the US, health care experts weighed in on possibilities of a future vaccine.

The H5 bird flu outbreak in the US started at the end of March 2024 when a commercial dairy farm worker in Texas reported conjunctivitis and shortly after tested positive for the bird flu.1 Since then, contaminated milk has been found on grocery store shelves, the first human without animal exposure contracted the virus, and 30 additional cases have been reported in the US. And with all of these developments ongoing, risk of a greater public health crisis spurred on by the bird flu is still considered low, according to public health experts.2

However, despite no...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Interview / Q&A, Pharma / Biotech, Public Health / COVID, Trends
What might a Trump administration mean for the Biosecure Act?
Flagship, Pfizer alliance yields two more startup deals
Wondr Health Expands Weight Loss Program with Support for GLP-1 Users
GeneDx Launches Tool to Fuel Rare Disease Drug Discovery
MedCity Pivot Podcast: Self-insured Employers Weigh Benefits of GLP-1 Drugs

Share This Article